|
US4078060A
(en)
|
1976-05-10 |
1978-03-07 |
Richardson-Merrell Inc. |
Method of inducing an estrogenic response
|
|
US4434228A
(en)
|
1982-04-20 |
1984-02-28 |
Genex Corporation |
Immobilization of biological materials in condensed polyalkyleneimine polymers
|
|
US4816568A
(en)
|
1986-05-16 |
1989-03-28 |
International Minerals & Chemical Corp. |
Stabilization of growth hormones
|
|
JPS63287730A
(ja)
|
1987-05-20 |
1988-11-24 |
Nippon Shokubai Kagaku Kogyo Co Ltd |
経皮吸収促進剤およびこれを含有してなる皮膚外用剤
|
|
US5420105A
(en)
|
1988-09-23 |
1995-05-30 |
Gustavson; Linda M. |
Polymeric carriers for non-covalent drug conjugation
|
|
US5252713A
(en)
*
|
1988-09-23 |
1993-10-12 |
Neorx Corporation |
Polymeric carriers for non-covalent drug conjugation
|
|
US5744166A
(en)
|
1989-02-25 |
1998-04-28 |
Danbiosyst Uk Limited |
Drug delivery compositions
|
|
US6126945A
(en)
*
|
1989-10-03 |
2000-10-03 |
Pharmacia Ab |
Tumor killing effects of enterotoxins, superantigens, and related compounds
|
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
|
US5670617A
(en)
|
1989-12-21 |
1997-09-23 |
Biogen Inc |
Nucleic acid conjugates of tat-derived transport polypeptides
|
|
US5629020A
(en)
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
|
DK0554284T3
(da)
|
1990-10-24 |
1997-01-06 |
Allelix Biopharma |
Peptid-baserede hæmmere af Hiv-replikation
|
|
GB9120306D0
(en)
|
1991-09-24 |
1991-11-06 |
Graham Herbert K |
Method and compositions for the treatment of cerebral palsy
|
|
US5607691A
(en)
|
1992-06-12 |
1997-03-04 |
Affymax Technologies N.V. |
Compositions and methods for enhanced drug delivery
|
|
EP0903408A3
(en)
|
1992-08-21 |
2005-11-02 |
Biogen, Inc. |
Tat-derived transport polypeptide
|
|
US5260082A
(en)
|
1992-09-16 |
1993-11-09 |
Kraft General Foods, Inc. |
Baked goods, doughs or batters, dry mixes and methods for producing thereof
|
|
US5877278A
(en)
*
|
1992-09-24 |
1999-03-02 |
Chiron Corporation |
Synthesis of N-substituted oligomers
|
|
US5709861A
(en)
|
1993-04-22 |
1998-01-20 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
|
US6974578B1
(en)
|
1993-12-28 |
2005-12-13 |
Allergan, Inc. |
Method for treating secretions and glands using botulinum toxin
|
|
US6986893B2
(en)
*
|
1993-12-28 |
2006-01-17 |
Allergan, Inc. |
Method for treating a mucus secretion
|
|
DE69434535T2
(de)
|
1993-12-28 |
2006-07-20 |
Allergan, Inc., Irvine |
Toxische Komponente der Botulinumtoxine zur Modulation cholinergisch kontrollierter Sekretionen
|
|
US5766605A
(en)
|
1994-04-15 |
1998-06-16 |
Mount Sinai School Of Medicine Of The City University Of New York |
Treatment of autonomic nerve dysfunction with botulinum toxin
|
|
ATE215832T1
(de)
*
|
1994-05-09 |
2002-04-15 |
William J Binder |
Botulinumtoxin zur reduktion von migraine - kopfschmerzen
|
|
NO180167C
(no)
|
1994-09-08 |
1997-02-26 |
Photocure As |
Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
|
|
US6232295B1
(en)
|
1994-10-12 |
2001-05-15 |
Jon Faiz Kayyem |
Cell-specific contrast agent and gene delivery vehicles
|
|
US5512547A
(en)
|
1994-10-13 |
1996-04-30 |
Wisconsin Alumni Research Foundation |
Pharmaceutical composition of botulinum neurotoxin and method of preparation
|
|
US5756468A
(en)
|
1994-10-13 |
1998-05-26 |
Wisconsin Alumni Research Foundation |
Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation
|
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
GB9508204D0
(en)
|
1995-04-21 |
1995-06-07 |
Speywood Lab Ltd |
A novel agent able to modify peripheral afferent function
|
|
GB9600272D0
(en)
|
1996-01-06 |
1996-03-06 |
Univ Nottingham |
Polymers
|
|
AU729643B2
(en)
|
1996-05-01 |
2001-02-08 |
Antivirals Inc. |
Polypeptide conjugates for transporting substances across cell membranes
|
|
US6444209B1
(en)
*
|
1996-10-28 |
2002-09-03 |
Wisconsin Alumni Research Foundation |
Hybrid botulinal neurotoxins
|
|
GB9623051D0
(en)
|
1996-11-06 |
1997-01-08 |
Schacht Etienne H |
Delivery of DNA to target cells in biological systems
|
|
FR2755976B1
(fr)
|
1996-11-15 |
1999-01-15 |
Idm Immuno Designed Molecules |
Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires
|
|
US6228161B1
(en)
|
1996-12-30 |
2001-05-08 |
Minerals Technologies Inc. |
Use of calcium carbonate in an acidic aqueous media
|
|
FR2759298B1
(fr)
|
1997-02-10 |
1999-04-09 |
Rhone Poulenc Rorer Sa |
Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees
|
|
ES2210761T3
(es)
|
1997-05-21 |
2004-07-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Composicion y procedimiento para mejorar el transporte a traves de las membranas biologicas.
|
|
US7150881B2
(en)
|
1997-06-26 |
2006-12-19 |
Mylan Technologies, Inc. |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
|
|
WO1999024596A1
(en)
|
1997-11-12 |
1999-05-20 |
Valentis, Inc. |
Expression plasmids for multiepitope nucleic acid-based vaccines
|
|
US5985434A
(en)
|
1997-11-25 |
1999-11-16 |
Kimberly-Clark Worldwide, Inc. |
Absorbent foam
|
|
CA2314267A1
(en)
|
1997-12-10 |
1999-06-17 |
Washington University |
Anti-pathogen system and methods of use thereof
|
|
WO1999042091A2
(en)
|
1998-02-19 |
1999-08-26 |
Massachusetts Institute Of Technology |
Use of polycations as endosomolytic agents
|
|
US6011646A
(en)
|
1998-02-20 |
2000-01-04 |
The Regents Of The Unviersity Of California |
Method to adjust multilayer film stress induced deformation of optics
|
|
EP1061951B1
(en)
|
1998-02-25 |
2003-08-27 |
THE GOVERNMENT OF THE UNITED STATES, as represented by THE SECRETARY OF THE ARMY |
Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
|
|
TR200003108T2
(tr)
|
1998-04-27 |
2001-02-21 |
Fujisawa Pharmaceutical Co., Ltd. |
İlaç kompozisyonları
|
|
US6261679B1
(en)
|
1998-05-22 |
2001-07-17 |
Kimberly-Clark Worldwide, Inc. |
Fibrous absorbent material and methods of making the same
|
|
CN1313873A
(zh)
*
|
1998-07-13 |
2001-09-19 |
表达遗传学公司 |
作为可溶性,生物可降解基因送递载体的聚－l－赖氨酸的聚酯类似物
|
|
US6280937B1
(en)
|
1998-08-14 |
2001-08-28 |
Rigel Pharmaceuticals, Inc. |
Shuttle vectors
|
|
TW574036B
(en)
|
1998-09-11 |
2004-02-01 |
Elan Pharm Inc |
Stable liquid compositions of botulinum toxin
|
|
US6958147B1
(en)
*
|
1998-10-26 |
2005-10-25 |
Licentia Ltd |
Use of VEGF-C to prevent restenosis
|
|
CA2347828A1
(en)
|
1998-10-27 |
2000-05-04 |
Mayo Foundation For Medical Education And Research |
Methods for enhancing wound healing
|
|
ES2213397T3
(es)
|
1998-12-02 |
2004-08-16 |
I.D.M. Immuno-Designed Molecules |
Nuevos conjugados oligomericos capaces de transferir moleculas biologicas a las celulas.
|
|
EP1137664A2
(en)
|
1998-12-10 |
2001-10-04 |
Washington University |
Protein transduction system and methods of use thereof
|
|
US6627632B2
(en)
*
|
1998-12-14 |
2003-09-30 |
Cellegy Pharmaceuticals, Inc. |
Compositions and methods for the treatment of anorectal disorders
|
|
CZ20012038A3
(cs)
|
1998-12-23 |
2001-09-12 |
Idea Ag |
Zdokonalený přípravek pro topické, neinvazivní použití in vivo
|
|
US7056656B1
(en)
*
|
1999-01-25 |
2006-06-06 |
University Of Medicine And Dentistry Of New Jersey |
Tat-derived oligourea and its method of production and use in high affinity and specific binding HIV-1 TAR RNA
|
|
ES2160485B1
(es)
|
1999-04-23 |
2002-05-16 |
Lipotec Sa |
Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
|
|
DE19925739A1
(de)
|
1999-06-07 |
2000-12-21 |
Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh |
Therapeutikum mit einem Botulinum-Neurotoxin
|
|
US7442764B2
(en)
*
|
1999-06-07 |
2008-10-28 |
Mirns Bio Corporation |
Reversible modification of amine-containing compounds
|
|
US20030236214A1
(en)
|
1999-06-09 |
2003-12-25 |
Wolff Jon A. |
Charge reversal of polyion complexes and treatment of peripheral occlusive disease
|
|
US7008924B1
(en)
*
|
1999-07-21 |
2006-03-07 |
Amgen, Inc. |
VGF fusion polypeptides
|
|
WO2001013957A2
(en)
|
1999-08-24 |
2001-03-01 |
Cellgate, Inc. |
Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
|
|
US7229961B2
(en)
|
1999-08-24 |
2007-06-12 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into ocular tissues
|
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
|
US20030104622A1
(en)
|
1999-09-01 |
2003-06-05 |
Robbins Paul D. |
Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
|
|
US6544548B1
(en)
*
|
1999-09-13 |
2003-04-08 |
Keraplast Technologies, Ltd. |
Keratin-based powders and hydrogel for pharmaceutical applications
|
|
US6458763B1
(en)
|
1999-09-17 |
2002-10-01 |
Depuy Orthopeadics |
Bone sialoprotein-based compositions for enhancing connective tissue repair
|
|
US6773928B1
(en)
*
|
1999-09-22 |
2004-08-10 |
The United States Of America As Represented By The Secretary Of The Army |
Compositions and methods for enhancing bioassay performance
|
|
US6610820B1
(en)
|
1999-10-12 |
2003-08-26 |
University Of Lausanne |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US6511676B1
(en)
*
|
1999-11-05 |
2003-01-28 |
Teni Boulikas |
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
|
|
US6844324B1
(en)
*
|
1999-11-12 |
2005-01-18 |
Massachusetts Institute Of Technology |
Modular peptide mediated intracellular delivery system and uses therefore
|
|
US7070807B2
(en)
|
1999-12-29 |
2006-07-04 |
Mixson A James |
Branched histidine copolymers and methods for using same
|
|
US20040109871A1
(en)
*
|
2000-01-06 |
2004-06-10 |
Pascual David W. |
M cell directed vaccines
|
|
US20030118598A1
(en)
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
|
ES2237551T3
(es)
*
|
2000-02-08 |
2005-08-01 |
Allergan, Inc. |
Composiciones farmaceuticas que contienen toxina botulinica.
|
|
US7780967B2
(en)
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
|
US20020009491A1
(en)
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
AT411041B
(de)
*
|
2000-05-18 |
2003-09-25 |
Josef Lindenberg |
Verfahren zur herstellung von glasfliesen, glasbordüren, glasdekorpaneelen oder dgl.
|
|
US6670322B2
(en)
|
2000-06-01 |
2003-12-30 |
Wisconsin Alumni Research Foundation |
Method of targeting pharmaceuticals to motor neurons
|
|
US6306423B1
(en)
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
|
US20040033241A1
(en)
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
|
US6306403B1
(en)
*
|
2000-06-14 |
2001-10-23 |
Allergan Sales, Inc. |
Method for treating parkinson's disease with a botulinum toxin
|
|
DK1301213T3
(en)
|
2000-07-21 |
2017-03-27 |
Revance Therapeutics Inc |
MULTI-COMPONENT SYSTEMS FOR BIOLOGICAL TRANSPORT
|
|
US20030219462A1
(en)
|
2000-07-21 |
2003-11-27 |
Allergan Sales, Inc |
Clostridial neurotoxin compositions and modified clostridial neurotoxins
|
|
US20040220100A1
(en)
*
|
2000-07-21 |
2004-11-04 |
Essentia Biosystems, Inc. |
Multi-component biological transport systems
|
|
US20030215412A1
(en)
|
2000-07-21 |
2003-11-20 |
Essentia Biosystems, Inc. |
Induction of hair growth with vascular endothelial growth factor
|
|
US6903187B1
(en)
*
|
2000-07-21 |
2005-06-07 |
Allergan, Inc. |
Leucine-based motif and clostridial neurotoxins
|
|
US7491799B2
(en)
|
2000-07-21 |
2009-02-17 |
Allergan, Inc. |
Modified botulinum neurotoxins
|
|
JP2002072267A
(ja)
*
|
2000-08-25 |
2002-03-12 |
National Institute For Materials Science |
光機能素子、該素子用単結晶基板、およびその使用方法
|
|
US6696038B1
(en)
*
|
2000-09-14 |
2004-02-24 |
Expression Genetics, Inc. |
Cationic lipopolymer as biocompatible gene delivery agent
|
|
US6831059B2
(en)
|
2000-10-20 |
2004-12-14 |
Allergan, Inc. |
Compositions and methods for treating gonadotrophin related illnesses
|
|
US20020127247A1
(en)
|
2000-11-17 |
2002-09-12 |
Allergen Sales, Inc. |
Modified clostridial neurotoxins with altered biological persistence
|
|
US7255865B2
(en)
|
2000-12-05 |
2007-08-14 |
Allergan, Inc. |
Methods of administering botulinum toxin
|
|
US20020086036A1
(en)
|
2000-12-05 |
2002-07-04 |
Allergan Sales, Inc. |
Methods for treating hyperhidrosis
|
|
DE60233137D1
(de)
|
2001-02-16 |
2009-09-10 |
Univ R |
Transporter mit beabstandeten arginin-teilchen
|
|
CA2437958C
(en)
*
|
2001-03-09 |
2018-10-30 |
University Of Chicago |
Polymeric immunoglobulin fusion proteins that target low-affinity fc.gamma.receptors
|
|
CA2367636C
(en)
*
|
2001-04-12 |
2010-05-04 |
Lisa Mckerracher |
Fusion proteins
|
|
JP4138651B2
(ja)
|
2001-07-27 |
2008-08-27 |
ボード オブ スーパーバイザーズ オブ ルイジアナ ステイト ユニバーシティ アンド アグリカルチュラル アンド メカニカル カレッジ |
にきび治療または防止のためのボツリヌス毒素
|
|
DE10146647A1
(de)
*
|
2001-09-21 |
2003-04-24 |
Marc Heckmann |
Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis
|
|
CA2465886A1
(en)
*
|
2001-11-07 |
2003-05-15 |
Kathleen S. Crowley |
Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
|
|
US7060498B1
(en)
|
2001-11-28 |
2006-06-13 |
Genta Salus Llc |
Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
|
|
MXPA04005611A
(es)
|
2001-12-11 |
2005-04-19 |
Cellgate Inc |
Reactivos y conjugados de transporte de guanidinio.
|
|
US20030113349A1
(en)
|
2001-12-18 |
2003-06-19 |
Coleman William P. |
Topically applied clostridium botulinum toxin compositions and treatment methods
|
|
US7364586B2
(en)
*
|
2001-12-21 |
2008-04-29 |
The Trustees Of Columbia University In The City Of New York |
C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis
|
|
US20030147958A1
(en)
*
|
2002-01-29 |
2003-08-07 |
Cheol-Hee Ahn |
Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol) for the delivery of bioactive agents
|
|
AU2003216389A1
(en)
|
2002-02-21 |
2003-09-09 |
Essentia Biosystems, Inc. |
Induction of hair growth with vascular endothelial growth factor
|
|
WO2003102166A2
(en)
|
2002-02-26 |
2003-12-11 |
Maxygen, Inc. |
Novel flavivirus antigens
|
|
AU2003219922B2
(en)
|
2002-02-27 |
2009-09-10 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
|
US6688311B2
(en)
|
2002-03-14 |
2004-02-10 |
Allergan, Inc. |
Method for determining effect of a clostridial toxin upon a muscle
|
|
US20030215395A1
(en)
*
|
2002-05-14 |
2003-11-20 |
Lei Yu |
Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
|
|
CN1383811A
(zh)
*
|
2002-05-16 |
2002-12-11 |
卢伟成 |
一种除皱化妆品及其制作工艺
|
|
US7459164B2
(en)
|
2002-05-28 |
2008-12-02 |
Botulinum Toxin Research Associates, Inc. |
Composition for therapeutic and cosmetic botulinum toxin
|
|
US20040013687A1
(en)
|
2002-05-31 |
2004-01-22 |
Thomas Jefferson University |
Compositions and methods for transepithelial molecular transport
|
|
US20040009180A1
(en)
|
2002-07-11 |
2004-01-15 |
Allergan, Inc. |
Transdermal botulinum toxin compositions
|
|
US20040242518A1
(en)
*
|
2002-09-28 |
2004-12-02 |
Massachusetts Institute Of Technology |
Influenza therapeutic
|
|
US9265725B2
(en)
*
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
|
US7071167B2
(en)
|
2002-11-13 |
2006-07-04 |
L'oreal |
Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines
|
|
AU2002350719A1
(en)
*
|
2002-11-29 |
2004-06-23 |
Janssen Pharmaceutica N.V. |
Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
|
|
US6866856B2
(en)
|
2002-12-31 |
2005-03-15 |
Avon Products, Inc. |
Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
|
|
WO2004084805A2
(en)
|
2003-03-19 |
2004-10-07 |
The J. David Gladstone Institutes |
Acetylated tat polypeptides and methods of use thereof
|
|
WO2004084905A2
(en)
|
2003-03-24 |
2004-10-07 |
University Of Florida |
Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions
|
|
WO2004084839A2
(en)
*
|
2003-03-24 |
2004-10-07 |
Cady Roger K |
Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin
|
|
US7341843B2
(en)
|
2003-04-11 |
2008-03-11 |
Allergan, Inc. |
Botulinum toxin A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
|
|
US20050074425A1
(en)
*
|
2003-07-02 |
2005-04-07 |
Polycord, Inc. |
Method for delivering polymerized therapeutic agent compositions and compositions thereof
|
|
US7883720B2
(en)
*
|
2003-07-09 |
2011-02-08 |
Wisconsin Alumni Research Foundation |
Charge-dynamic polymers and delivery of anionic compounds
|
|
DE10333317A1
(de)
|
2003-07-22 |
2005-02-17 |
Biotecon Therapeutics Gmbh |
Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA)
|
|
US8871224B2
(en)
*
|
2003-12-09 |
2014-10-28 |
Allergan, Inc. |
Botulinum toxin therapy for skin disorders
|
|
US9211248B2
(en)
*
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
HUE025656T2
(en)
|
2004-03-03 |
2016-04-28 |
Revance Therapeutics Inc |
Topical application and transdermal delivery of botulinum toxins
|
|
BRPI0508440A
(pt)
*
|
2004-03-03 |
2007-07-24 |
Revance Therapeutics Inc |
composições e métodos para diagnóstico tópico e transporte terapêutico
|
|
US7691381B2
(en)
|
2004-04-15 |
2010-04-06 |
Allergan, Inc. |
Stabilized biodegradable neurotoxin implants
|
|
US20060040882A1
(en)
|
2004-05-04 |
2006-02-23 |
Lishan Chen |
Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
|
|
GB2416122A
(en)
|
2004-07-12 |
2006-01-18 |
Ipsen Ltd |
Botulinum neurotoxin composition
|
|
EP1786459B1
(en)
*
|
2004-07-26 |
2014-02-12 |
Merz Pharma GmbH & Co. KGaA |
Therapeutic composition whit a botulinum neurotoxin
|
|
US20060024331A1
(en)
|
2004-08-02 |
2006-02-02 |
Ester Fernandez-Salas |
Toxin compounds with enhanced membrane translocation characteristics
|
|
JP2006067889A
(ja)
*
|
2004-09-01 |
2006-03-16 |
Japan Science & Technology Agency |
Ｐｅｏと二本鎖核酸のコンジュゲート
|
|
KR20070110402A
(ko)
|
2005-03-03 |
2007-11-16 |
레반스 테라퓨틱스 |
보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법
|
|
ES2362301T3
(es)
*
|
2005-03-03 |
2011-07-01 |
Revance Therapeutics, Inc. |
Composiciones y procedimientos para aplicaciones tópicas y liberación transdérmica de un oligopéptido.
|
|
US20100116664A1
(en)
*
|
2005-03-08 |
2010-05-13 |
Ignatius Michael J |
Monitoring and manipulating cellular transmembrane potentials using nanostructures
|
|
ES2535084T3
(es)
*
|
2005-05-11 |
2015-05-05 |
Eth Zurich |
Proteínas N-glicosiladas recombinantes procedentes de células procariotas
|
|
DE102005039189B4
(de)
|
2005-08-18 |
2010-09-09 |
Siemens Ag |
Bildauswertungsverfahren für zweidimensionale Projektionsbilder und hiermit korrespondierende Gegenstände
|
|
US8137677B2
(en)
*
|
2005-10-06 |
2012-03-20 |
Allergan, Inc. |
Non-protein stabilized clostridial toxin pharmaceutical compositions
|
|
US8168206B1
(en)
*
|
2005-10-06 |
2012-05-01 |
Allergan, Inc. |
Animal protein-free pharmaceutical compositions
|
|
WO2007059528A2
(en)
*
|
2005-11-17 |
2007-05-24 |
Revance Therapeutics, Inc. |
Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
|
|
US9486408B2
(en)
*
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
WO2008082889A2
(en)
*
|
2006-12-29 |
2008-07-10 |
Revance Therapeutics, Inc. |
Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from hiv-tat
|
|
US20100021502A1
(en)
|
2006-12-28 |
2010-01-28 |
Waugh Jacob M |
Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins Stabililzed with Polypeptide Fragments Derived from HIV-TAT
|
|
NZ598159A
(en)
*
|
2006-12-29 |
2013-08-30 |
Revance Therapeutics Inc |
Transport molecules using reverse sequence hiv-tat polypeptides
|
|
SI2257307T1
(sl)
*
|
2008-02-20 |
2018-09-28 |
Glaxosmithkline Biologicals S.A. |
Biokonjugati, izdelani iz rekombinantnih N-glikoziliranih proteinov iz prokariontskih celic
|
|
US20170361130A9
(en)
*
|
2008-05-23 |
2017-12-21 |
Pankaj Modi |
Stabilized and solubilized drug formulation for topical application and transdermal efficacy for cosmetic improvement and methods of formulation
|
|
US20100028385A1
(en)
*
|
2008-08-04 |
2010-02-04 |
Allergan, Inc. |
Treatment of excess cerumen secretion
|
|
MX2011002757A
(es)
*
|
2008-09-29 |
2011-04-07 |
Panasonic Corp |
Medio de informacion de grabacion, metodo de grabacion y metodo de reproduccion.
|
|
LT2379104T
(lt)
*
|
2008-12-31 |
2018-04-10 |
Revance Therapeutics, Inc. |
Injekcinės botulino toksino vaisto formos
|
|
US20120014894A1
(en)
*
|
2008-12-31 |
2012-01-19 |
Revance Therapeutics, Inc. |
Compositions and Methods for Treating Hyperpigmentation
|
|
MX2011010335A
(es)
*
|
2009-04-01 |
2012-01-12 |
Revance Therapeutics Inc |
Metodos y composiciones para tratar afecciones de la piel asociadas con hiperreactividad vascular.
|
|
CN102869373B
(zh)
*
|
2009-06-25 |
2017-05-10 |
雷文斯治疗公司 |
不含白蛋白的肉毒杆菌毒素制剂
|
|
US9737500B2
(en)
*
|
2010-10-29 |
2017-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
|
US9504664B2
(en)
*
|
2010-10-29 |
2016-11-29 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
|
ES3036435T3
(en)
*
|
2011-01-07 |
2025-09-18 |
Revance Therapeutics Inc |
Kits for topical application, removal, and inactivation of therapeutic or cosmetic botulinum toxin compositions
|
|
US8697090B2
(en)
*
|
2011-05-05 |
2014-04-15 |
Allergan, Inc. |
Method of treating persistent genital arousal disorder with a neurotoxin
|
|
US8586020B2
(en)
*
|
2011-06-30 |
2013-11-19 |
Korea Institute Of Science And Technology |
Poly(organophosphazene) composition for biomaterials
|
|
WO2013040417A1
(en)
*
|
2011-09-16 |
2013-03-21 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center |
Amphiphilic cationic polymers for the delivery of therapeutic agents
|
|
ES2923757T3
(es)
*
|
2011-12-16 |
2022-09-30 |
Modernatx Inc |
Composiciones de ARNm modificado
|
|
MX2014009083A
(es)
*
|
2012-01-27 |
2015-07-17 |
Revance Therapeutics Inc |
Metodos y escalas de evaluacion para la medicion de la gravedad de las arrugas.
|
|
US20130251770A1
(en)
*
|
2012-03-22 |
2013-09-26 |
Revance Therapeutics, Inc. |
Method of Treatment of Wrinkles Using Topical Chemodenervating Agents
|
|
US9541558B2
(en)
*
|
2012-09-05 |
2017-01-10 |
California Institute Of Technology |
Cysteine hydrazide nicotinamide for glycomics and glycoproteomics uses
|
|
WO2014066916A2
(en)
*
|
2012-10-28 |
2014-05-01 |
Revance Therapeutics, Inc. |
Compositions and methods for safe treatment of rhinitis
|
|
US20150259283A1
(en)
*
|
2014-03-13 |
2015-09-17 |
Brickell Biotech, Inc. |
Formulation for soft anticholinergic analogs
|
|
AU2015252947B2
(en)
*
|
2014-05-01 |
2020-07-09 |
Anterios, Inc. |
Demonstrable efficacy across or within patient populations
|
|
MX380066B
(es)
*
|
2014-12-23 |
2025-03-11 |
Merz Pharma Gmbh & Co Kgaa |
Recipiente precargado con toxina botulinica.
|
|
KR102627068B1
(ko)
*
|
2015-02-03 |
2024-01-18 |
메르츠 파마 게엠베하 운트 코. 카가아 |
보툴리눔 독소 사전충전된 용기
|
|
CN109069608A
(zh)
*
|
2015-10-29 |
2018-12-21 |
雷文斯治疗公司 |
具有长的治疗或美容效应持续时间的可注射肉毒杆菌毒素制剂以及其使用方法
|
|
CA3020400A1
(en)
*
|
2016-04-12 |
2017-10-19 |
Illustris Pharmaceuticals, Inc. |
Compositions for topical application of compounds
|
|
CA3078631A1
(en)
*
|
2017-10-11 |
2019-04-18 |
Jacob M. Waugh |
Methods and compositions for topical delivery
|
|
CN116764088A
(zh)
*
|
2018-08-15 |
2023-09-19 |
阿勒根公司 |
具有活性成分的微针阵列
|